Since 2014, our customers have received over 90% of new drug and biologic approvals by the FDA. These FDA approvals span across several designations and therapeutic areas, including oncology, infectious disease, hematology, pulmonology, cardiology, dermatology, diabetes, neurology, gastroenterology, psychiatry, bone, migraine, sleep disorders and more. View the case studies below to see for yourself.
Featured Case Studies
Cloud-based software helps Asia-Pacific (APAC) generic drug company achieve the impossible
Get the latest from CertaraSubscribe to receive the latest resources